The genetics of drug efficacy: opportunities and challenges.

Abstract excerpt

Lack of sufficient efficacy is the most common cause of attrition in late-phase drug development. It has long been envisioned that genetics could drive stratified drug development by identifying those patient subgroups that are most likely to respond. However, this vision has not been realized as only a small proportion of drugs have been found to have germline genetic predictors of efficacy with clinically...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biomarkers, Pharmacological
• Share to Drug Discovery